468 related articles for article (PubMed ID: 8413524)
21. Prescription opiate medications: medical uses and consequences, laws and controls.
Miller NS
Psychiatr Clin North Am; 2004 Dec; 27(4):689-708. PubMed ID: 15550288
[TBL] [Abstract][Full Text] [Related]
22. Drug diversion control systems, medical practice, and patient care.
Haislip GR
NIDA Res Monogr; 1993; 131():120-31. PubMed ID: 8413522
[No Abstract] [Full Text] [Related]
23. New York State's Triplicate Prescription Program.
Eadie JL
NIDA Res Monogr; 1993; 131():176-93. PubMed ID: 8413528
[No Abstract] [Full Text] [Related]
24. Balancing diversion control and medical necessity: the case of prescription drugs with abuse potential.
Simoni-Wastila L; Tompkins C
Subst Use Misuse; 2001; 36(9-10):1275-96. PubMed ID: 11592473
[TBL] [Abstract][Full Text] [Related]
25. AMA spearheads national effort to prevent prescription drug abuse.
Occup Health Nurs; 1983 Feb; 31(2):46. PubMed ID: 6550252
[No Abstract] [Full Text] [Related]
26. Diversion investigation units--methods, utilities, and limitations.
Bulla RK
NIDA Res Monogr; 1993; 131():145-50. PubMed ID: 8413525
[No Abstract] [Full Text] [Related]
27. Resting assured: risk management in the prescription of controlled substances.
Longo LP
WMJ; 1999; 98(1):23-9. PubMed ID: 10050150
[No Abstract] [Full Text] [Related]
28. Drug diverting patients & prescription monitoring--both sides of the debate.
Freeman J
Iowa Med; 2004; 94(5):10-1. PubMed ID: 15560649
[No Abstract] [Full Text] [Related]
29. Va. doctors to report controlled substances. Program targets drugs with high potential for abuse, e.g., oxycontin, percocet.
Lubell J
Mod Healthc; 2006 Jun; 36(26):32. PubMed ID: 16841650
[No Abstract] [Full Text] [Related]
30. States respond to growing abuse of painkiller.
Wasserman S
State Legis; 2001; 27(9):33-4. PubMed ID: 11763873
[TBL] [Abstract][Full Text] [Related]
31. A flood of opioids, a rising tide of deaths.
Okie S
N Engl J Med; 2010 Nov; 363(21):1981-5. PubMed ID: 21083382
[No Abstract] [Full Text] [Related]
32. Summary and conclusions of a review of prescription drug diversion control methods.
Horgan C; Prottas J; Tompkins C; Wastila L; Bowden M
NIDA Res Monogr; 1993; 131():206-23. PubMed ID: 8413532
[No Abstract] [Full Text] [Related]
33. Recognizing preventing and medication diversion.
Cole BE
Fam Pract Manag; 2001 Oct; 8(9):37-41. PubMed ID: 11685867
[No Abstract] [Full Text] [Related]
34. Dangers of self-prescribing and prescribing for family members.
Price M; McIntyre BW
Med Health R I; 2007 Jun; 90(6):178-81. PubMed ID: 17633590
[No Abstract] [Full Text] [Related]
35. Controlled substances bill biggest healthcare issue of session.
W V Med J; 2012; 108(3):102. PubMed ID: 22792665
[No Abstract] [Full Text] [Related]
36. Decreasing use of controlled-release oxycodone: response to Morden et al, June 2008 Medical Care.
Katz MH; Kotabe S
Med Care; 2008 Sep; 46(9):1002. PubMed ID: 18725857
[No Abstract] [Full Text] [Related]
37. Excessive dispensing of controlled substances: a legal perspective.
Morgan WR
Ala Med; 1985 Feb; 54(8):13-7. PubMed ID: 3976450
[No Abstract] [Full Text] [Related]
38. Inappropriate use of DEA numbers.
Roberts WF
J Miss State Med Assoc; 1997 Dec; 38(12):455. PubMed ID: 9415775
[No Abstract] [Full Text] [Related]
39. Fifteen solutions to the problems of prescription drug abuse.
Lurie P; Lee PR
J Psychoactive Drugs; 1991; 23(4):349-57. PubMed ID: 1813607
[TBL] [Abstract][Full Text] [Related]
40. Prescription drug regulation: implications for nursing and health care delivery--response of the American Nurses' Association.
Naegle MA
NIDA Res Monogr; 1993; 131():228-34. PubMed ID: 8413534
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
